Disseminated intravascular coagulation

Seminars in Oncology Nursing - Tập 15 - Trang 174-182 - 1999
Barbara Holmes Gobel1,2
1Gottlieb Memorial Hospital, Melrose Park, IL, USA
2Complemental faculty, Rush University College of Nursing, Chicago, IL, USA

Tài liệu tham khảo

Kempin, 1997, Hemostatic defects in cancer patients, Cancer Invest, 15, 23, 10.3109/07357909709018914 Bick, 1996, Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response, Semin Thromb Hemost, 22, 69, 10.1055/s-2007-998993 Bick, 1994, Disseminated intravascular coagulation. Objective criteria for diagnosis and management, Med Clin North Am, 78, 519, 10.1016/S0025-7125(16)30145-6 Bavier, 1994, Coagulopathies, 729 Bick, 1992, Hemostasis in malignancy, 239 Bick, 1992, Coagulation abnormalities in malignancy, Semin Thromb Hemost, 18, 353, 10.1055/s-2007-1002575 Bick, 1993, Alterations of hemostasis in malignancy, 1583 Bick, 1996, Thrombosis and hemorrhage in oncology patients, Hematol Oncol Clin North Am, 10, 875, 10.1016/S0889-8588(05)70374-9 Jesty, 1995, The pathways of coagulation, 1149 Gobel, 1997, Bleeding disorders, 604 Pruett, 1996, Bleeding, 269 Bone, 1992, Modulators of coagulation. A critical appraisal of their role in sepsis, Arch Intern Med, 152, 1381, 10.1001/archinte.1992.00400190023007 Williams, 1997, Disseminated intravascular coagulation, 1758 Bunn, 1993, Paraneoplastic syndromes, 2026 Goodnough, 1991, Management of disseminated intravascular coagulation, 373 Kurtz, 1993, Disseminated intravascular coagulation with leukemia patients, Cancer Nurs, 16, 456, 10.1097/00002820-199312000-00005 Seto, 1996, Tranexamic acid in oncology, Ann Pharmacother, 30, 868, 10.1177/106002809603000728 Shpilberg, 1995, A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia, Leuk Lymph, 19, 141, 10.3109/10428199509059668 Murphy-Ende, 1998, Disseminated intravascular coagulation, 119 Bick, 1998, Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations, Semin Thromb Hemost, 24, 3, 10.1055/s-2007-994971 Butler, 1991, Systemic release of neutrophil elastase and tumor necrosis factor alpha following ABO incompatible blood transfusion, Br J Hematol, 79, 525, 10.1111/j.1365-2141.1991.tb08069.x Lankiewicz, 1993, Disseminated intravascular coagulation, 110 Bick, 1992, Disseminated intravascular coagulation, 137 Bick, 1992, Disseminated intravascular coagulation, Hematol Oncol Clin North Am, 6, 1259, 10.1016/S0889-8588(18)30274-0 Marder, 1993, Clinical aspects of consumptive thrombohemorrhagic disorders, 665 Rutherford, 1994, Thrombocytopenia: Issues in diagnosis and therapy, Med Clin North Am, 78, 555, 10.1016/S0025-7125(16)30147-X Bick, 1992, Diagnostic efficacy of the D-dimer assay in DIC and related disorders, Thromb Res, 65, 785, 10.1016/0049-3848(92)90116-R Okamoto, 1992, Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: Determination of prothrombin fragment 1 & 2 and other markers, Haemostasis, 22, 17 Staudinger, 1996, Management of acquired coagulation disorders in emergency and intensive-care medicine, Semin Thromb Hemost, 22, 93, 10.1055/s-2007-998995 Takahashi, 1988, Plasmin-alpha-2 plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation, Am J Hematol, 28, 162, 10.1002/ajh.2830280306 Riewald, 1998, Treatment options for clinically recognized disseminated intravascular coagulation, Semin Thromb Hemost, 24, 53, 10.1055/s-2007-995823 Rubin, 1992, Disseminated intravascular coagulation. Approach to treatment, Drugs, 44, 963, 10.2165/00003495-199244060-00005 Vinazzer, 1995, Antithrombin III in shock and disseminated intravascular coagulation, Clin Appl Thromb Hemost, 1, 62, 10.1177/107602969500100110 Fourrier, 1993, Double-blind placebo controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation, Chest, 104, 882, 10.1378/chest.104.3.882 Dickneite, 1994, Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis, Thromb Hemost, 71, 772 Nowak, 1991, Hirudin in disseminated intravascular coagulation, Haemostasis, 21, 142 Okamura, 1993, Treatment of disseminated intravascular coagulation and its prodromal stage with gabexate mesilate (FOY): A multi-center trial, Acta Haematol, 90, 120, 10.1159/000204391 Gilbert, 1993, Disseminated intravascular coagulation, Emerg Med Clin North Am, 11, 465, 10.1016/S0733-8627(20)30643-X Menitove, 1995, Preparation and clinical use of plasma and plasma fractions, 1649 Kitchens, 1995, Disseminated intravascular coagulation, 182